Objective: The main objective of this study was to retrospectively evaluate that the cytogenetic abnormalities is an important prognostic factor for the cure of acute myeloid leukemia (AML).
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NTRODUCTION
Acute Leukemia belong to the group of hematopoietic stem cell mutation clone malignancy which is characterized by certain blood cells of hematopoietic tissue system hyperplasia, and infiltration to the bloodstream and then to various tissues and organs, which led to a series of clinical manifestations.
In China, pediatric malignancies have the highest incidence of leukemia. With the continuous improvement of chemotherapy, the rapid development of immunology, cytogenetic and molecular genetics, it is no longer considered a fatal disease. Complete remission rate of initial treatment in children with acute myeloid leukemia has reached 80% and five year disease-free survival rate of about 40 -60%.
Over the past years, blood disease research work caught committed to explore the pathogenesis of acute leukemia from cytogenetic and molecular level that the considerable number of leukemia is chromosomal changes because of genetic abnormalities. Oncogene activation, tumor suppressor gene deletion, causing the proliferation of hematopoietic cells, differentiation and regulation disorders, to malignant transformation.
With the advancement of cultivation method and banding techniques, currently age-related macular degeneration (AMD) chromosomal aberrations detected rate has risen from 50% in the 1960s and 1970s and the current to around 80% -90%. Although the type of AML chromosomal aberrations up to 100 or more, But it can be summarized into two categories: one is FAB subtypespecific chromosomal rearrangements related, about 60%, including the t (8; 21) (q22; q22), t (15; 17) (q 22; q12 or 21), inv (16) (p13; q22) etc.
Where in t (8; 21) (q22; q22) is closely related to AML-M2, t (15; 17) (q22; q12 or 21) found only in AML-M3, inv (16) (p13; q22) more common in M4EO. Such karyotype on early diagnosis and classification of AML has a guide. FAB subtype and the other is not related to abnormal, most of the number of abnormal, common chromosome number has increased first 8, 21, 19, 11 and 22 there appears chromosome loss, Y chromosome 7, 5 and 12, common chromosome 16 deletion of the short arm missing 6 and No. 7, 5 and 1, 12, 3. Among them +8, -7, -5 are the most.
Over the years, more cooperative groups abroad, including SWOG (South West Oncology Group), MRC (Medical Research Council) analyzed by a large sample of cases, confirmed cytogenetic findings prognosis and significance for acute myeloid leukemia. In accordance with the prognosis of low-risk group divided cytogenetic risk groups and high-risk groups that differences in each group complete remission rate, overall survival, disease free survival time were significant, although each between the study groups of individual cytogenetic abnormalities prognostic significance remains controversial, but most of the prognostic significance of cytogenetic abnormalities results are consistent and clear.
Simple t (8; 21), and with t (15; 17), the general prognosis in patients with inv (16) change is good, with -7, -5, inv (3) (q21; q26) / t (3; 3) (q21; q26) or complex karyotype chromosome abnormalities, poor prognosis. Thus, by cytogenetic characteristics of prognostic evaluation, selection the appropriate treatment is essential to prolong the survival rate of patients.
In this study, 70 cases of hospitalized patients with recently diagnosed AML from January 2009-2015 February were enrolled with karyotype abnormalities, patients with acute myeloid leukemia were involved in the treatment to understand AML patients karyotype distribution, survival follow-up and outcome combined with the clinical diagnosis and treatment. The aim is to analyze the correlation between karyotype and prognosis. 
METHODS
Study
Specimen collection
Patients admitted to hospital after chromosome analysis, samples were obtained from the bone marrow cells before and after treatment in patients from iliac spine. Five ml injection containing two ml broth, culture bottles were immediately taken for inspection.
Cytogenetic analysis
The samples were submitted to the Second Affiliated Hospital of Anhui Medical University, Laboratory of Hematology line karyotype. Direct method or short-term legal culture piece, karyotype analysis using G banding analysis of 20 metaphase cells, press "Human cytogenetic international nomenclature system (ISCN1995)" were to be carried out 2 .
At least two cells having the same or increase in chromosome structural rearrangements, or three cells having the same chromosome loss, will be confirmed as an exception clone. Recurrence was defined by one of the following three criteria including (1) bone marrow blasts >5% and = 20%, after a course of an effective anti-leukemic treatment, bone marrow failed to achieve complete remission. (2) Bone marrow blasts >20%; (3) myeloid leukemia cell infiltration. Overall survival is defined as the time of diagnosis until death or end of follow-up. Disease-free survival is defined as the time to achieve complete remission to relapse during this time, if more than one relapse and remission as per the cumulative basis.
Treatment and efficacy evaluation
Experimental Method
Reagent
(1) Medium: containing 20% fetal calf serum and 20 µ/ml heparin RPMI l640.
(2) Mitosis blockers: colchicines, formulated 5 µg/ml were used. 
Step
(1) Take specimens and inoculation culture: Sterile needle to extract bone marrow fluid 0.5 ~ 2 mL in heparin tube, add broth to 8 mL, washing and percussion, centrifugation (1200 rpm/min, 5 min), repeated 2 -3 times to wash away the fat and other impurities. Per ml medium 1 ~ 3 × 106 cells were inoculated to a sterile culture medium containing 5 ml in to two flasks, shake gently and placed in the box 37 for 48 hours.
(2) Colchicines treatment: Sample bottle was added with colchicines 50 µl, using liquid 0.05 ml (final concentration 0.05 µg/mL) to continue to foster 50 min.
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2) The prewarmed 8 ml hypotonic solutions added by repeatedly pipetting at 37 o C with bubble method, water bath for 30 minutes.
3) PreFixed: Add fixative 1 ~ 5mL, percussion mix placed under room temperature 3 ~ 5 min.
4) Centrifugation: 800 to 1000 rev / min.
5) Fixed:
The supernatant was discarded, freshly prepared fixative was added to 5 ~ 6 mL, mix by pipetting.
6) Centrifugation: 800 to 1000 rev / min, 10 minutes 7) Repeat 5 and 6 steps two times.
8) The supernatant was discarded, adding an appropriate amount of fixative gently pipetting the cell suspension to spare.
9) Drop sheet: Take number of slides that stored in clean ice cold wet sheets, slightly tilted, with a capillary dropper suction cell suspension, dropping from 10 cm height of one to two drops on the slide in the air to be dry. 1) The first, vat 25 mL (0.1%) mixed with trypsin 25 mL (0.02%) EDTA solution, Tris was adjusted to pH 7. Second, three vat 50 mL were added at pH 6.8 phosphate buffer. The fourth was added 50 mL (5%) Giemsa dye vat. The three dye vats were kept at 37 o C water bath.
2) Slide into the first cylinder 20 -30 seconds, remove successively rinsed in the second, three-cylinder, followed by the third set dye vat five to 10 minutes.
3) Tap water, dry equipment seized.
4) Each patient observed for at least 20 metaphase cells, abnormal karyotype press "Human Cytogenetic Nomenclature System (ISCN 1995)" are identified and described.
Statistical Methods
ISPSS17.0 software statistics was used for statistical analysis. Groups were compared using chi-square test;
Survival rate was calculated by method of Kaplan Meier and survival difference between groups were compared with breslow test.
RESULTS
Among 70 cases, 42 cases were detected for chromosomal abnormalities, i.e. 60% of the total number of cases. 
DISCUSSION
With the continuous improvement of chromosome banding techniques, especially the rapid development of high-resolution technology, such chromosomal abnormalities relationship between certain types of leukemia and has become more and more closely, but also identified a number of subtypes iconic chromosome abnormal characteristics. Meanwhile, with disease progression or improvement of chromosomal abnormality occurs constantly changing, these changes we adjust has a significant role in the treatment and prognosis of the disease. In most patients, the application of cytogenetic methods can be found in clear cell clonal chromosomal abnormalities. The same chromosomal abnormalities are also seen in acute leukemia (AL) of each subtype, which means not only the diagnosis, but also prognostic value, the clinical characteristics of patients; help us to predict the patient's condition, because the merits of any karyotype changes are not absolute. Chromosomal abnormalities are important prognostic factor, such as t (8; 21) and t (15; 17) or inv (16) [6] [7] .
Acute myeloid leukemia part differentiation type (M2) and t (8; 21)
t (8; 21) is the first to be identified as chromosomal abnormalities in AML, seen in AML-M2, especially in childhood AML is more common, a few also found in AML-M4. In adults, t (8; 21) prognosis is good, but in children, the prognosis is poor. Foucar K 8 reported 11 cases of t (8; 21) patients, nine cases of M2, two cases of M4, M4's two cases were five and 11 years old, after allogeneic hematopoietic stem cell transplantation to achieve complete remission, nine cases M2, seven cases of complete remission. t (8; 21) showed no difference between the proportion of this group of patients. The patients in all AML t (8; 21) a total of 13 cases, 10 cases of remission, remission rate was 78.5%, 86.7% seen in M2. Prigogina 
Clinical relationship of karyotypes inv (16) (p13; q22)
The patients of inv (16) (p13; q22) there are two cases, one case exists in M4, achieve remission, one case of M5, did not achieve remission. The patients were males, aged four, WBC 56. × 10 9 / L) difficult to achieve CR. 65.3%, the prognosis is moderate.
Clinical relationship of normal karyotype
This group of patients with normal karyotype had 28 patients, seven cases of NR, response rate was 75%, means for survival time is 78.5 ±7.5 month. Torstein Haferlach 16 and other reports analyzed 453 cases of newly diagnosed AML patients. It showed normal karyotype and abnormal +8, prognosis medium.
CONCLUSIONS
This article summarizes 70 cases of children with acute myeloid leukemia untreated cases, the application of short-term culture and/ or direct method to do G-banding karyotype analysis, all patients of acute myeloid leukemia were given standard regimen and observed cytogenetic karyotype relations and efficacy, the following conclusions occur:
(1) Acute myeloid leukemia cell has its genetic basis, diagnosis of chromosomal studies in acute myeloid leukemia are important in treatment and prognosis.
